Arno Therapeutics, Inc 4
4 · Arno Therapeutics, Inc · Filed Oct 31, 2013
Insider Transaction Report
Form 4
HAMILTON WILLIAM F PHD
Director
Transactions
- Purchase
Common Stock
2013-10-29+20,833→ 22,079 total - Purchase
2013 Series D Warrants (right to buy)
2013-10-29+20,833→ 20,833 totalExercise: $4.00From: 2013-10-29Exp: 2018-10-29→ Common Stock (20,833 underlying) - Purchase
2013 Series E Warrants (right to buy)
2013-10-29+20,833→ 20,833 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (20,833 underlying)
Holdings
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2019-09-29→ Common Stock (3,750 underlying) - 1,250
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (1,250 underlying)
Footnotes (3)
- [F1]The reported securities are included within 20,833 Issuer units purchased by the Reporting Person for $2.40 per unit. Each unit consists of one share of common stock, a 2013 Series D Warrant to purchase one share of common stock, and a 2013 Series E Warrant to purchase one share of common stock.
- [F2]Currently exercisable.
- [F3]Vests in three equal annual installments commencing 11/5/11.